For an estimated 31 million Americans, the simple act of existing in one’s own skin is a...
LONDON, UK – In a landmark international study led by researchers at University College London (UCL), a...
Fifty-five years after the Controlled Substances Act of 1970 relegated psilocybin to Schedule I status—placing it alongside...
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting served as a definitive turning point for...
A groundbreaking shift in how the medical community approaches neurodegenerative disease is currently underway, led by a...
Executive Summary: A Milestone in Structural Heart Intervention VDyne, a clinical-stage medical device company specializing in transformative...
Introduction: A Global Health Imperative Cancer remains one of humanity’s most formidable adversaries, exacting a devastating physical,...
NEW YORK — In the traditional narrative of oncology, the focus has long been directed toward the...
In a bold move to reshape the landscape of oncology in Canada, Breast Cancer Canada (BCC) has...
Frisco, Texas – For years, Shona, an elected official in Frisco, Texas, maintained a consistent routine, a...
